4//SEC Filing
ENDOCYTE INC 4
Accession 0001144204-15-006845
CIK 0001235007operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 8:02 PM ET
Size
8.8 KB
Accession
0001144204-15-006845
Insider Transaction Report
Form 4
ENDOCYTE INCECYT
Nguyen Binh
VP of Clinical Affairs
Transactions
- Award
Common Stock
2015-02-04+8,750→ 18,950 total - Tax Payment
Common Stock
2015-02-06$5.14/sh−708$3,639→ 18,242 total - Award
Stock Option (right to buy)
2015-02-04+52,500→ 52,500 totalExercise: $5.10Exp: 2025-02-04→ Common Stock (52,500 underlying)
Footnotes (3)
- [F1]Represents restricted stock units that will vest and be paid 1/3 annually over a period of 3 years beginning on February 4, 2016, in the form of one share of common stock for each restricted stock unit.
- [F2]Represents shares withheld to satisfy tax withholding obligations associated with the settlement of 1,875 restricted stock units in the form of Company common stock on a one-for-one basis on February 6, 2015.
- [F3]Shares subject to the option vest 1/3 annually over a period of 3 years beginning on February 4, 2016.
Documents
Issuer
ENDOCYTE INC
CIK 0001235007
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001235007
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 8:02 PM ET
- Size
- 8.8 KB